Dr. Anis Rehman, MD, Dipl. ABOM
• M.B., B.S. (Dow Medical College, Pakistan, 2011) • Diplomate in Endocrinology, Diabetes, & Metabolism, American Board of Internal Medicine (Dec 2018) • Diplomate in Obesity Medicine, American Board of Obesity Medicine (Apr 2021)
• Edward Via College of Osteopathic Medicine, Blacksburg, VA • District Endocrine LLC, Woodbridge, VA
Affiliations
• Mid-Atlantic Society of Endocrinologists (Board Member) • North American Society of Interventional Endocrinologists • American Association of Clinical Endocrinologists • Committee on Publication Ethics, UK
About the editor

Dr. Anis Rehman is an esteemed endocrinologist and assistant professor with a career focused on diabetes, endocrinology, and metabolism. Currently serving as an Assistant Professor at Edward Via College and Medical Director at District Endocrine LLC, he brings over a decade of experience in clinical and academic roles. Dr. Rehman is highly published, with 894 citations and expertise spanning clinical trials, meta-analyses, and systematic reviews on cardiovascular and metabolic diseases. He holds significant editorial roles, contributes to medical publications, and has a deep commitment to advancing endocrine research and educating future medical professionals.

Publications
Research Article
Comprehensive evaluation of cardiovascular efficacy and safety outcomes of SGLT2 inhibitors in high risk patients of cardiovascular disease: systematic review and meta-analysis
Copyright © Journal of Pioneering Medical Sciences until unless otherwise.